Roundtable on Black in cancer research and oncology - presented by Dr. Brandon Blue MD and Dr. Kilan Ashad-Bishop and Drs. Onyinye and Folu Balogun and Runcie C.W. Chidebe Dip., BSc., MSc., and Kathryn Mcginnis and Dr Paraskevi Mallini and Dr. Lisa Hoffmann-Haas

Roundtable on Black in cancer research and oncology

Brandon Blue, Kilan Ashad-Bishop, Onyinye and Folu Balogun and Runcie C.W. Chidebe

Dr. Brandon Blue MDDr. Kilan Ashad-BishopDrs. Onyinye and Folu BalogunRuncie C.W. Chidebe Dip., BSc., MSc.,
Slide at 21:57
Uterine Cancer Mortality in NYC The Onc Docs Dr. On. White women Uterine Cancer Mortality by Year and Race, New York City, 1976-2016 6.6 deaths per 100,000 women - Blacks Whites 7.1 deaths per 100,000 women Black women 8.7 deaths per 100,000 women 1980 1990 2000 2010 10.8 deaths per 100,000 women Year Weill Cornell Medicine NewYork-Presbyterian
Share slide
Summary (AI generated)

And so, we are currently attempting to determine the cause behind this occurrence. Several studies have been conducted, one of which is particularly noteworthy - the study conducted by Doctor Felix. The purpose of this study was to explore the disparities in outcomes based on race and ethnicity within the context of the gog 2 10.

Doctor Felix's findings revealed that black women are more prone to experiencing recurrence of the disease compared to non-Hispanic white women. Furthermore, they are also at a higher risk of mortality as a result of this illness.